RVL Pharmaceuticals plc (NASDAQ: RVLPQ) — Healthcare · Share Price, Chart & Market Data
About: RVL Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, Argentina, and Hungary. It focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.00
RVLPQRVL Pharmaceuticals plc
Loading watchlist status…
Trade RVLPQ now
RVL Pharmaceuticals plc share price
RVLPQ price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 12:25 pm GMT+0
RVLPQ price performance
-100%
5D
-100%
1M
-100%
YTD
-100%
1Y
RVLPQ price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 12:25 pm GMT+0
RVLPQ details
RVLPQ Market Signals